The complex (IGF-I/IGFBP-3) formed can be used to treat growth hormone insensitivity syndrome (GHIS) and reduce insulin requirement in patients with diabetes [4]. This evidence concerns the gene IGFBP3 and growth hormone insensitivity syndrome.